D.C. Mun. Regs. tit. 22, r. 22-B207

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 22-B207 - HEPATITIS B TESTING AND VACCINATION

207.1

A provider that attends to, treats, or examines a pregnant woman or provides perinatal treatment shall:

(a) Take a blood sample during the first prenatal visit and submit the sample to a laboratory approved by the Department for testing for Hepatitis B Surface Antigen (HBsAg);

(b) Take a blood sample at the time of delivery if the woman has not had prior perinatal services or no documentation of HBsAg status, and submit the sample to a laboratory approved by the Department for testing HBsAg;

(c) Maintain a record of the woman's Hepatitis B status in her patient file; and

(d) Make a report according to the requirements of section 201.5.

207.2

A provider that delivers a newborn shall:

(a) Document the mother's Hepatitis B status in the newborn's records;

(b) Immunize the newborn for the Hepatitis B virus; and

(c) Make a report according to the requirements of section 207.7.

207.3

A newborn whose mother tests positive for HBsAg shall:

(a) Receive Hepatitis B immunoglobulin (HBIG) and Hepatitis B vaccine within twelve (12) hours of birth according to the recommendations of the Advisory Committee on Immunization Practices (ACIP);

(b) Receive a complete Hepatitis B series according to the schedule found at 22 DCMR § 135; and

(c) Receive post-vaccination testing for the presence of HBsAg and Hepatitis B Surface Antibody (HBsAb) three (3) months after the last dose of Hepatitis B vaccine but not earlier than nine (9) months of age and no later than nineteen (19) months of age.

207.4

A newborn whose mother's HBsAg status is unknown shall:

(a) Receive Hepatitis B vaccine without HBIG within twelve (12) hours of birth;

(b) Receive HBIG as soon as possible but no later than seven (7) days after birth if the newborn's mother tests positive for HBsAg;

(c) Receive a complete Hepatitis B series according to the schedule found at 22 DCMR § 135; and

(d) Receive post-vaccination testing for the presence of HBsAg and Hepatitis B Surface Antibody (HBsAb) three (3) months after the last dose of Hepatitis B vaccine but not earlier than nine (9) months of age and no later than nineteen (19) months of age.

207.5

A full-term medically stable newborn weighing two thousand grams (2000g) or more born to a mother who is HBsAg-negative shall:

(a) Receive Hepatitis B vaccine before hospital discharge; and

(b) Receive a complete Hepatitis B series according to the schedule found at 22 DCMR § 135.

207.6

A pre-term newborn weighing less than two thousand grams (2000g) born to a mother who is HBsAg-negative shall:

(a) Receive the first dose of Hepatitis B vaccine one (1) month after birth or at hospital discharge; and

(b) Receive a complete Hepatitis B series according to the schedule found at 22 DCMR § 135.

207.7

In addition to the reporting requirements of section 201.5, a provider shall also report the following in the manner and form the Director requires:

(a) The date and time that Hepatitis B vaccine was administered;

(c) The date and time that Hepatitis B immunoglobulin was administered;

(d) The manufacturer of the vaccine; and

(e) The vaccine lot number.

207.8

A newborn's parent or legal guardian shall be deemed to have consented to Hepatitis B vaccination, unless the newborn's parent or legal guardian submits a signed request for exemption that states the reasons for the exemption. A newborn may be exempted from vaccination if:

(a) The newborn's mother tested negative for HBsAg;

(b) The newborn's parent or legal guardian objects in good faith and in writing that immunization would violate his or her religious beliefs; or

(c) The newborn's parent or legal guardian provides the written certification of a physician that immunization is medically inadvisable.

207.9

Information disclosed to the Department pursuant to this section shall be kept confidential and shall not be disclosed to a third party, except as provided in this subsection. The Department may use and disclose information received pursuant to this section as follows:

(a) The Director may use patient-specific immunization information:

(1) To produce aggregate immunization coverage reports and to track Hepatitis B levels;

(2) To ensure that newborns receive Hepatitis B immunization;

(3) To conduct follow-up on infants born to HBsAg positive mothers; and

(4) For statistical and public health purposes.

(b) Except as provided in subsection (a), the Director may disclose a person's individually identifiable information to a third party only with written consent of the person, or the person's parent or guardian if the person is under eighteen (18) years of age or an unemancipated adult.

D.C. Mun. Regs. tit. 22, r. 22-B207

Final Rulemaking published at 55 DCR 5980 (May 23, 2008)